DC Council legislation calls for mandatory HPV vaccination for schoolgirls

Share this article:
The District of Columbia Council voted 7 to 3 in favor of approving legislation that calls for young girls to be immunized against the human papillomavirus (HPV), which causes cervical cancer, The Washington Post reported. DC officials said they would launch an aggressive education campaign to inform the public about the vaccine and make it easy for parents to opt out for any reason. Under the legislation, when school begins in 2009, girls entering sixth grade must prove they have been vaccinated against HPV, unless their parents or guardians excuse them. If the legislation is signed and approved by Democratic Mayor Adrian Fenty and approved by Congress, it would be similar to legislation adopted in Virginia earlier this month, according to The Washington Post report. Merck currently markets Gardasil, the only approved HPV vaccine. Meanwhile, GlaxoSmithKline filed for FDA approval for its HPV vaccine Cervarix earlier this month.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...